Grand Pharmaceutical Group Limited (0512.HK)
HKD 4.76
(-0.83%)
HKD 4.76
(-0.83%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | 10.52 Billion | 9.56 Billion | 8.59 Billion | 6.35 Billion | 6.59 Billion | 5.95 Billion |
| Cost of Revenue | 4 Billion | 3.61 Billion | 3.35 Billion | 2.31 Billion | 2.55 Billion | 2.79 Billion |
| Gross Profit | 6.52 Billion | 5.95 Billion | 5.24 Billion | 4.03 Billion | 4.03 Billion | 3.16 Billion |
| Operating Expenses | 3.86 Billion | 3.43 Billion | 3.22 Billion | 2.52 Billion | 2.86 Billion | 2.08 Billion |
| Selling, General and Administrative Expenses | 3.28 Billion | 2.9 Billion | 2.89 Billion | 2.3 Billion | 2.68 Billion | 2.31 Billion |
| Research and Development Expenses | 571.98 Million | 531.92 Million | 331.42 Million | 219.31 Million | 186.13 Million | 137.49 Million |
| Other Expenses | - | 40.24 Million | 46.15 Million | 41.07 Million | 38.36 Million | 38.66 Million |
| Cost and Expenses | 7.86 Billion | 7.04 Billion | 6.57 Billion | 4.84 Billion | 5.42 Billion | 4.88 Billion |
| Operating Income | 2.66 Billion | 2.51 Billion | 2.01 Billion | 1.5 Billion | 1.16 Billion | 892.3 Million |
| Interest Expense | 205.14 Million | 137.49 Million | 92.96 Million | 115.42 Million | 146.5 Million | 203.29 Million |
| Income Tax Expense | 448.75 Million | 418.64 Million | 380.8 Million | 292.37 Million | 230.48 Million | 147.46 Million |
| Earnings before Tax | 2.34 Billion | 2.56 Billion | 2.67 Billion | 2.01 Billion | 1.24 Billion | 883.89 Million |
| Net Income | 1.87 Billion | 2.07 Billion | 2.4 Billion | 1.79 Billion | 1.15 Billion | 712.66 Million |
| Earnings Per Share Basic | 0.54 | 0.59 | 0.68 | 0.52 | 0.35 | 0.27 |
| Earnings Per Share Diluted | 0.54 | 0.59 | 0.68 | 0.52 | 0.34 | 0.26 |
| Weighted Average Shares Outstanding | 3.5 Billion | 3.54 Billion | 3.54 Billion | 3.44 Billion | 3.27 Billion | 2.68 Billion |
| Weighted Average Shares Outstanding (Diluted) | 3.5 Billion | 3.54 Billion | 3.54 Billion | 3.44 Billion | 3.37 Billion | 2.79 Billion |
| Gross Margin | 0.62 | 0.62 | 0.61 | 0.64 | 0.61 | 0.53 |
| EBIT Margin | 0.28 | 0.30 | 0.27 | 0.28 | 0.25 | 0.19 |
| Profit Margin | 0.18 | 0.22 | 0.28 | 0.28 | 0.17 | 0.12 |
| EBITDA | 2.96 Billion | 3.09 Billion | 3.1 Billion | 2.41 Billion | 1.86 Billion | 1.32 Billion |
| Earnings Before Tax Margin | 0.25 | 0.26 | 0.23 | 0.24 | 0.18 | 0.15 |
| Breakdown | 2024 Q2 | 2023 FY | 2023 Q4 | 2023 Q2 | 2022 FY | 2022 Q4 |
|---|---|---|---|---|---|---|
| Revenue | 6.04 Billion | 10.52 Billion | 4.54 Billion | 5.98 Billion | 9.56 Billion | 4.34 Billion |
| Cost of Revenue | 2.45 Billion | 4 Billion | 1.88 Billion | 2.12 Billion | 3.61 Billion | 1.65 Billion |
| Gross Profit | 3.59 Billion | 6.52 Billion | 2.65 Billion | 3.86 Billion | 5.95 Billion | 2.69 Billion |
| Operating Expenses | 2.21 Billion | 3.86 Billion | 1.52 Billion | 2.33 Billion | 3.43 Billion | 1.44 Billion |
| Selling, General and Administrative Expenses | 1.91 Billion | - | 1.31 Billion | 1.97 Billion | - | 1.16 Billion |
| Research and Development Expenses | 300.67 Million | - | 216 Million | 355.97 Million | - | 279.06 Million |
| Other Expenses | - | 35.27 Million | - | - | 40.24 Million | - |
| Cost and Expenses | 4.67 Billion | 7.86 Billion | 3.41 Billion | 4.45 Billion | 7.04 Billion | 3.09 Billion |
| Operating Income | 1.37 Billion | 2.66 Billion | 1.12 Billion | 1.53 Billion | 2.51 Billion | 1.25 Billion |
| Interest Expense | 86.12 Million | 205.14 Million | 91.91 Million | 113.23 Million | 137.49 Million | 74.28 Million |
| Income Tax Expense | 244.17 Million | 448.75 Million | 179.82 Million | 268.92 Million | 418.64 Million | 200.86 Million |
| Earnings before Tax | 1.81 Billion | 2.36 Billion | 1.03 Billion | 1.33 Billion | 2.56 Billion | 1.59 Billion |
| Net Income | 1.55 Billion | 1.87 Billion | 850.64 Million | 1.02 Billion | 2.07 Billion | 1.36 Billion |
| Earnings Per Share Basic | 0.44 | - | 0.24 | 0.29 | - | 0.39 |
| Earnings Per Share Diluted | 0.44 | - | 0.24 | 0.29 | - | 0.39 |
| Weighted Average Shares Outstanding | 3.5 Billion | 3.5 Billion | 3.5 Billion | 3.53 Billion | 3.54 Billion | 3.51 Billion |
| Weighted Average Shares Outstanding (Diluted) | 3.5 Billion | 3.5 Billion | 3.5 Billion | 3.53 Billion | 3.54 Billion | 3.51 Billion |
| Gross Margin | 0.59 | 0.62 | 0.58 | 0.65 | 0.62 | 0.62 |
| EBIT Margin | 0.27 | - | 0.29 | 0.29 | - | 0.34 |
| Profit Margin | 0.26 | 0.18 | 0.19 | 0.17 | 0.22 | 0.31 |
| EBITDA | 1.62 Billion | - | 1.32 Billion | 1.72 Billion | - | 1.47 Billion |
| Earnings Before Tax Margin | 0.23 | 0.25 | 0.25 | 0.26 | 0.26 | 0.29 |
SMIN
2331
LXRX
NORSF
3711
3728